VXVictor W. Xia

Victor W. Xia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Victor W. Xia has a total of 194 co-authors. Here are the top co-authors by number of shared publications:

  • Randolph H. Steadman

    Department of Anesthesiology and Critical Care Houston Methodist Hospital Houston Texas USA

    21 shared publications
  • Ronald W. Busuttil

    12 shared publications
  • Christopher Wray

    Department of Anesthesiology and Perioperative Medicine, Ronald Reagan UCLA Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA

    11 shared publications
  • Vatche Agopian

    Departments of Surgery, Ronald Reagan UCLA Medical Center David Geffen School of Medicine at UCLA Los Angeles California USA

    6 shared publications
  • Christine Nguyen-Buckley

    Department of Anesthesiology and Perioperative Medicine, Ronald Reagan UCLA Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA

    5 shared publications
  • Christopher Wray

    Department of Anesthesiology and Perioperative Medicine Ronald Reagan UCLA Medical Center, David Geffen School of Medicine at UCLA Los Angeles California USA

    5 shared publications

Latest Publications

  • Open Access

    Liver transplantation at the extreme: Analysis of outcomes and predictors of futility in patients with acute-on-chronic liver failure grade 3 on maximal life support

    by Andrew Melehy, Asara Thepbunchonchai, Benjamin V. Tran, Ruben Hernaez, Dominic Amara, Samer Ebaid, Daniela Markovic, Fady M. Kaldas, Igor Barjaktarevic, Victor Xia, et al.


  • Open Access

    Normothermia Machine Perfusion Is Associated With Reduced Transfusion Requirements, Improved Hemodynamic Stability, and Decreased Vasopressor Use During the Postreperfusion Phase of Liver Transplantation

    by Xian Zhao, Samer Ebaid, Nickolas Feduska, Christian Park, Fady Kaldas, Christopher Wray, Victor W. Xia

    Background: Normothermic machine perfusion (NMP) has emerged as a valuable preservation technique, expanding the donor pool and improving clinical outcomes in liver transplantation (LT). Despite its growing adoption and reported advantages, the perioperative impact of NMP remains incompletely defined. In this study, we aimed to investigate the effects of NMP versus static cold storage (SCS) on postreperfusion blood product utilization, hemodynamics, and vasopressor requirements. Methods: We conducted a retrospective cohort study of adult LT patients at our institution between January 2017 and November 2024. The NMP and SCS groups were matched using propensity scores generated from preoperative and prereperfusion variables. Results: A total of 1059 patients underwent LT, including 86 NMP and 973 SCS patients. Before matching, significant differences were noted in several preoperative and prereperfusion variables. After 1:3 propensity match, these differences were eliminated. Post‐match analysis showed that the NMP group required significantly fewer transfusions (approximately 40% reduction observed across all blood products). NMP was also associated with significantly higher mean arterial pressure and reduced vasopressor requirements following reperfusion. Conclusions: NMP was associated with reduced blood transfusion, improved hemodynamic stability, and decreased vasopressor support during the postreperfusion phase of LT.


  • Open Access

    Association Between Liver Graft to Recipient Weight Ratio and Acute Kidney Injury Following Liver Transplantation: A Historical Cohort Study

    by Maxime Soucy‐Proulx, Francois Martin Carrier, Christian Vincelette, Tristan Grogan, Victor Xia, Christopher Wray, Mansi Sheth, Christine Nguyen‐Buckley, Stephanie Roullet, Joanna Ramadan, et al.

    Introduction: Acute kidney injury (AKI) is a frequent complication following liver transplantation (LT) that has a multifactorial etiology. While some perioperative risk factors have been associated with postoperative AKI, the impact of liver graft weight to recipient body weight ratio (GW/RBW) has been poorly explored. We hypothesized that a high GW/RBW ratio would be associated with AKI after LT.Methods: This single‐center historical cohort study included all consecutive adults who had LT at Paul Brousse Hospital between 2018 and 2022. Patients requiring preoperative renal replacement therapy, combined solid organ transplantation, retransplantation, split or domino graft were excluded, as well as those with missing graft weight and creatinine values during the first postoperative week. The primary exposure was GW/RBW ratio expressed as a proportion. The primary outcome was the incidence of postoperative AKI within 7 days after surgery, defined using the Kidney Disease: Improving Global Outcomes (KDIGO) criteria. The secondary outcome was the AKI severity (KDIGO grades). We estimated logistic and ordinal regression models adjusted for potential confounding factors and explored nonlinear associations.Results: Of 467 patients analyzed, 211 (45%) developed AKI. A high GW/RBW ratio was associated with both the risk of postoperative AKI and the severity of AKI (KDIGO grades), especially above a threshold of 2.5% (non‐linear effect).Conclusion: A high GW/RBW ratio was associated with an exponential increase in the risk of AKI after LT. A high GW/RBW ratio was also associated with an increased AKI severity. Our findings may help improve graft allocation in patients undergoing LT.

  • Intraoperative Mean Arterial Pressure and Postoperative Delayed Graft Function in Kidney Transplantation: Evaluating Three Commonly Used Thresholds

    by Chinnarat Pongpruksa, Nutchanok Khampitak, Drew Chang, Suphamai Bunnapradist, Hans Gritsch, Victor W. Xia

    Background: Delayed graft function (DGF) is a common early complication after kidney transplantation (KT) and is associated with various long‐term adverse outcomes. Despite numerous studies on hemodynamic management, the optimal hemodynamic goals during KT remain unclear. In this retrospective study, we aimed to investigate if three mean artery pressure (MAP) thresholds (≤75, 80, and 85 mmHg) that were commonly used in clinical practice were associated with DGF in adult patients undergoing KT.Methods: We extracted de‐identified data on adult patients who underwent deceased donor KT from our Discovery Data Repository. DGF was defined as the requirement for dialysis within the first 7 days after transplantation. Three MAP thresholds (≤75, 80, and 85 mmHg) and the duration of pressure below the three thresholds were recorded. Multivariable logistic analysis was used to identify risk factors for DGF.Results: We included 2301 adult KT patients. The mean age was 52.5±12.9 years and 59% were male. DGF occurred in 1066 patients (46.3%). Patients frequently experienced MAP ≤75, 80, and 85 mmHg (approximately 70%, 80%, and 90% of patients experienced 10 min of MAP ≤75, 80, and 85 mmHg, respectively). Patients with DGF spent significantly longer durations below the three MAP thresholds during surgery compared with those without DGF. Further analysis revealed that the minimal time spent on MAP ≤75, 80, and 85 mmHg that were significantly associated with DGF were 6, 23, and 37 min, respectively. After adjusting for non‐hemodynamic risk factors (age, basiliximab administration, and urine output), prolonged exposure to the three MAP thresholds remained significant predictors for DGF (for MAP ≤75 mmHg, OR 1.257, 95% CI 1.017–1.554, p = 0.034; MAP ≤80 mmHg, OR 1.220, 95% CI 1.018–1.463, p = 0.031; MAP ≤85 mmHg, OR 1.253, 95% CI 1.048–1.498, p = 0.013).Conclusion: Prolonged exposure to the three common MAP thresholds (≤75, 80, and 85 mmHg) occurred frequently during adult deceased donor KT and was associated with DGF.


  • High Postreperfusion Pulmonary Artery Pressure Is Associated With Increased 30-Day Mortality in Liver Transplantation

    by Nutchanok Khampitak, Chinnarat Pongpruksa, Drew Cheng, Christine Myo Bui, Sophia Poorsattar, Christopher Wray, Victor W. Xia


  • Open Access

    Low‐dose tissue plasminogen activator is safe and effective in treating major intracardiac thrombosis in liver transplant recipients

    by Christine Nguyen‐Buckley, Victor Xia, Mansi Sheth, Tristan Grogan, Sara Arastoo, Jennifer Scovotti, Fady Kaldas, Christopher Wray

    Background: Major intracardiac thrombosis is an uncommon event during liver transplantation and has a high mortality rate. Given concerns for hemorrhage in liver transplantation with higher doses, low‐dose tissue plasminogen activator has been proposed as a treatment that rapidly leads to localized clot lysis and resolution of right ventricular failure.Methods: This is a retrospective study using a prospectively collected database at the University of California at Los Angeles of liver transplant recipients from 2004‐2021. Adult patients who received tissue plasminogen activator for intracardiac thrombosis detected on transesophageal echocardiography were included.Results: Out of 3236 liver transplants from 2016 to 2021, 11 liver transplant recipients were treated with intravenous low‐dose tissue plasminogen activator for major intracardiac thrombosis. The TPA dose range was 1–2.5 mg with three patients receiving more than one dose. All patients had severe hemodynamic instability. 90.9% of patients had right ventricular failure and 63.6% had cardiac arrest. After administration of low‐dose tissue plasminogen activator, 100% of patients had clinical improvement, clot resolution, and intraoperative survival, with 91% survival at 6 months post‐transplant. Adverse events included two patients with abdominal bleeding requiring re‐exploration and three patients having new intracranial hemorrhage which self‐resolved.Conclusions: Low dose tissue plasminogen activator was effective in treating major intracardiac thrombosis in our group of patients. Major complications included a limited number of hemorrhagic events.


  • Utility of preoperative troponin I to predict mortality in adult liver transplant recipients: Revisiting pretransplant cardiac risk in the current MELD‐allocation era

    by Christopher L. Wray, Victor W. Xia, Brent D. Ershoff, Sherri Fields, Jennifer C. Scovotti, Tristan Grogan, Henry M. Honda, Fady M. Kaldas

    Background: Preoperative risk assessment in liver transplant (LT) candidates, particularly related to cardiac risk, is an area of intense interest for transplant clinicians. Various cardiac testing methods are employed by transplant centers to characterize cardiac risk. Serum troponin is an established method for the detection of myocardial injury in a wide variety of clinical settings. Preoperative troponin screening has been reported to predict postoperative cardiac events and mortality in various surgical patient populations, however, the utility of preoperative troponin to predict posttransplant outcomes in current LT candidate populations requires further investigation.Methods: We performed a prospective blinded study in a cohort of 275 consecutive LT recipients at a single transplant center to determine if preoperative serum troponin I (TnI) was predictive for postoperative 1‐year mortality.Results: Abnormal preoperative TnI levels (>.1 ng/mL) were found in 38 patients (14%). One‐year mortality occurred in 19 patients (7%). There was no significant difference in mortality between patients with normal and abnormal troponin levels. Additionally, we found that there was no significant difference in early postoperative major adverse cardiac events between patient groups.Conclusions: Contrary to previous reports, elevated preoperative TnI was not significantly predictive of posttransplant mortality in LT recipients at our institution.


  • Super‐massive transfusion during liver transplantation

    by Warangkana Lapisatepun, Christina Ma, Worakitti Lapisatepun, Vatche Agopian, Christopher Wray, Victor W. Xia

    Background: Massive hemorrhage and transfusion during liver transplantation (LT) present great challenges. We aimed to investigate the incidence and risk factors for super‐massive transfusion (SMT) and survival outcome and factors that negatively affect survival in patients who received SMT during LT.Study Design and Methods: We included adult patients undergoing LT from 2004 to 2019. SMT was defined as transfusion of ≥50 units of red blood cells (RBC) during LT. Independent risk factors were identified by multivariable logistic regression. Ninety‐day survival was recorded and factors that negatively affected survival were analyzed by the Cox survival test.Results: Of 2772 patients, 158 (5.6%) received SMT during LT. Mean RBC transfusion was 72.6 (±23.4) units with a maximum of 168 units. Four variables (MELD‐Na score, previous upper abdominal surgery, portal vein thrombosis, and remote retransplant) were independent risk factors for SMT (odds ratio 1.800–8.274, 95% CI 1.008–16.685, all p < .005). The 90‐day survival rate in SMT patients was 81.6%. Preoperative pulmonary hypertension and massive postreperfusion transfusion negatively affected 90‐day survival (hazard ratio 2.658–4.633, 95% CI 1.144–10.130, and all p < .05).Conclusions: In this large retrospective study, we found that SMT occurred in a small percentage of patients and was associated with relatively satisfactory short‐term survival. Identification of preoperative risk factors for SMT and factors that negatively affect survival improve our understanding of this unique LT patient population.


  • Open Access

    Intraoperative Hypotension and 30-D Mortality After Liver Transplantation

    by Libing Wang, Christine Myo Bui, Ira Hofer, Eilon Gabel, Christopher Wray, Victor W. Xia

    Background.: Intraoperative hypotension (IOH) is common and associated with mortality in major surgery. Although patients undergoing liver transplantation (LT) have low baseline blood pressure, the relation between blood pressure and mortality in LT is not well studied. We aimed to determine mean arterial pressure (MAP) that was associated with 30-d mortality in LT. Methods.: We performed a retrospective cohort study. The data included patient demographics, pertinent preoperative and intraoperative variables, and MAP using various metrics and thresholds. The endpoint was 30-d mortality after LT. Results.: One thousand one hundred seventy-eight patients from 2013 to 2020 were included. A majority of patients were exposed to IOH and many for a long period. Eighty-nine patients (7.6%) died within 30 d after LT. The unadjusted analysis showed that predicted mortality was associated with MAP P = 0.002, 0.036, and 0.047), respectively. Exposure to MAP <60 mm Hg up to 120 min was not associated with increased mortality. Conclusion.: In this large retrospective study, we found IOH was common during LT. Intraoperative MAP <55 mm Hg was associated with increased 30-d mortality after LT, and the duration associated with postoperative mortality was shorter with lower MAP than with higher MAP.